跳至主要内容
临床试验/IRCT2016050716077N5
IRCT2016050716077N5已完成未知

Evaluating effect of the zinc as a supplement to methylphenidate in children suffering ADHD

Vice Chancellor for research of Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
7 years 至 12 years(—)
性别
All

入选标准

  • children aged between 7 to 12 years; ADHD diagnosis made by youth and children psychiatry subspecialist according to DSM-IV criteria and approved by K-SADS form; no prohibition to consumption of the zinc supplements such as copper consumption; IQ more than 70; without any other psychiatric disorders approved by K-SADS form; no history of zinc consumption during last two months; receiving methylphenidate tablet in 0.5 to 1 mg/kg/day doses as treatment
  • Exclusion criteria: cancelling participation by parents or child consciously; not consuming according to the prescription; change in treatment method; interrupting treatment due to any reason such as drug adverse effects

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for research of Tabriz University of Medical Sciences

相似试验